United States - English - NLM (National Library of Medicine)

hospira, inc. - amiodarone hydrochloride (unii: 976728sy6z) (amiodarone - unii:n3rq532iut) - amiodarone hydrochloride 50 mg in 1 ml

New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - amiodarone hydrochloride 50 mg/ml - concentrate for injection - 50 mg/ml - active: amiodarone hydrochloride 50 mg/ml excipient: benzyl alcohol hydrochloric acid polysorbate 80 sodium hydroxide water for injection - treatment should be initiated only under hospital or specialist supervision. indicated for treatment of · tachyarrhythmias associated with wolff-parkinson-white syndrome. · all types of tachyarrhythmias including · supraventricular, nodal and ventricular tachycardias, atrial flutter and fibrillation; · ventricular fibrillation; · when other agents cannot be used. the injection is to be used when a rapid response is required.

United States - English - NLM (National Library of Medicine)

hf acquisition co llc, dba healthfirst - amiodarone hydrochloride (unii: 976728sy6z) (amiodarone - unii:n3rq532iut) - amiodarone hcl injection is indicated for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia in patients refractory to other therapy. amiodarone hcl injection also can be used to treat patients with vt/vf for whom oral amiodarone is indicated, but who are unable to take oral medication. during or after treatment with amiodarone hcl injection, patients may be transferred to oral amiodarone therapy (see dosage & administration). amiodarone hcl injection should be used for acute treatment until the patient’s ventricular arrhythmias are stabilized. most patients will require this therapy for 48 to 96 hours, but amiodarone hcl injection may be safely administered for longer periods if necessary. amiodarone hcl injection is contraindicated in patients with known hypersensitivity to any of the components of amiodarone hcl injection, including iodine, or in patients with cardiogenic shock, marked sinus bradycardia, and secon

United States - English - NLM (National Library of Medicine)

baxter healthcare corporation - amiodarone hydrochloride (unii: 976728sy6z) (amiodarone - unii:n3rq532iut) - amiodarone hydrochloride 1.5 mg in 1 ml - nexterone is indicated for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation (vf) and hemodynamically unstable ventricular tachycardia (vt) in patients refractory to other therapy. nexterone is contraindicated in patients with: risk summary available data from postmarketing reports and published case series indicate that amiodarone use in pregnant women may increase the risk for fetal adverse effects including neonatal hypo- and hyperthyroidism, neonatal bradycardia, neurodevelopmental abnormalities, preterm birth and fetal growth restriction. amiodarone and its metabolite, desethylamiodarone (dea), cross the placenta. untreated underlying arrhythmias, including ventricular arrhythmias, during pregnancy pose a risk to the mother and fetus (see clinical considerations). in animal studies, administration of amiodarone to rabbits, rats, and mice during organogenesis resulted in embryo-fetal toxicity at doses less than the maximum recommended human maintenance dose (see

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

toa eiyo ltd. - amiodarone hydrochloride - injection

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - amiodarone hydrochloride - solution for injection - 30mg/1ml

New Zealand - English - Medsafe (Medicines Safety Authority)

max health limited - amiodarone hydrochloride 50 mg/ml;   - concentrate for injection - 150 mg/3ml - active: amiodarone hydrochloride 50 mg/ml   excipient: benzyl alcohol nitrogen polysorbate 80 water for injection - tachyarrhythmias associated with wolff-parkinson-white syndrome. all types of tachyarrhythmias including: - supraventricular, nodal and ventricular tachycardias, atrial flutter and fibrillation; - ventricular fibrillation; - when other agents cannot be used. the injection is to be used when a rapid response is required. treatment should be initiated only under hospital or specialist supervision.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - amiodarone hydrochloride, quantity: 150 mg - injection, solution - excipient ingredients: polysorbate 80; benzyl alcohol; water for injections - severe cases of tachyarrhythmias (eg. wolff-parkinson-white syndrome, supraventricular, nodal and ventricular tachycardias, atrial flutter and fibrillation, ventricular fibrillation) not responding to other therapy. treatment should be initiated in hospital. it is recommended that the patient should be regularly monitored for possible toxicity (eg. thyroid function, chest x-ray, ophthalmological examination, liver function etc.) during the entire course of therapy and for several months after discontinuation. cordarone x intravenous may be used for treatment initiated in a hospital for severe cases of tachyarrhythmias (atrial, junctional and ventricular) not responding to other therapy and when a rapid response is required. cordarone x intravenous should only be used where facilities exist for cardiac monitoring and defibrillation should the need arise

Israel - English - Ministry of Health

sanofi israel ltd - amiodarone hydrochloride - solution for injection - amiodarone hydrochloride 50 mg / 1 ml - amiodarone - amiodarone - treatment should be initiated and normally monitored only under hospital or specialist supervision. amiodacore injection is indicated for corronary insufficiency, arrhythmias resistant to other treatments, wolf parkinson white syndrome.amiodacore intravenous can be used where a rapid response is required or where oral administration is not possible.

Malta - English - Medicines Authority

ibigen s.r.l via fossignano, 2, 04011 aprilia (lt), italy - amiodarone hydrochloride - concentrate for solution for infusion or injection - amiodarone hydrochloride 150 mg - cardiac therapy